Unlike most other cancers, our in vivo studies showed that adiponectin deficiency could significantly alleviate pancreatic cancer growth and metastasis, suggesting that there is an unconventional role of adiponectin in the promotion of pancreatic cancer progression. Here, ADIPOQ is linked to familial pancreatic carcinoma.